I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| enterocyte | 3 studies | 29% ± 15% | |
| ciliated cell | 3 studies | 25% ± 6% | |
| goblet cell | 3 studies | 25% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| enterocyte | 3 studies | 29% ± 15% | |
| ciliated cell | 3 studies | 25% ± 6% | |
| goblet cell | 3 studies | 25% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 3 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 854.28 | 226 / 226 | 90% | 8.05 | 364 / 406 |
| intestine | 66% | 644.54 | 641 / 966 | 81% | 2.96 | 426 / 527 |
| kidney | 96% | 407.57 | 85 / 89 | 35% | 0.80 | 315 / 901 |
| bladder | 81% | 301.38 | 17 / 21 | 38% | 1.85 | 189 / 504 |
| lung | 96% | 162.25 | 555 / 578 | 13% | 0.55 | 147 / 1155 |
| stomach | 18% | 4.83 | 64 / 359 | 78% | 3.00 | 222 / 286 |
| adrenal gland | 65% | 29.54 | 168 / 258 | 0% | 0 | 0 / 230 |
| spleen | 60% | 16.51 | 145 / 241 | 0% | 0 | 0 / 0 |
| uterus | 46% | 21.39 | 78 / 170 | 6% | 0.36 | 27 / 459 |
| pancreas | 12% | 5.60 | 40 / 328 | 39% | 1.25 | 69 / 178 |
| esophagus | 18% | 7.44 | 266 / 1445 | 31% | 1.11 | 56 / 183 |
| breast | 48% | 40.19 | 220 / 459 | 0% | 0.01 | 5 / 1118 |
| adipose | 44% | 21.74 | 533 / 1204 | 0% | 0 | 0 / 0 |
| prostate | 28% | 9.80 | 69 / 245 | 0% | 0.01 | 2 / 502 |
| skin | 11% | 4.11 | 205 / 1809 | 1% | 0.01 | 3 / 472 |
| thymus | 11% | 2.66 | 69 / 653 | 0% | 0.01 | 2 / 605 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.14 | 2 / 29 |
| peripheral blood | 6% | 2.95 | 54 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 5% | 1.16 | 61 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 4% | 1.22 | 8 / 180 | 0% | 0 | 0 / 430 |
| brain | 2% | 0.61 | 66 / 2642 | 0% | 0 | 0 / 705 |
| heart | 0% | 0.05 | 2 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.02 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO_0070098 | Biological process | chemokine-mediated signaling pathway |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_0006954 | Biological process | inflammatory response |
| GO_0006874 | Biological process | intracellular calcium ion homeostasis |
| GO_0006935 | Biological process | chemotaxis |
| GO_0043547 | Biological process | positive regulation of GTPase activity |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_0048245 | Biological process | eosinophil chemotaxis |
| GO_0050918 | Biological process | positive chemotaxis |
| GO_0005615 | Cellular component | extracellular space |
| GO_0048020 | Molecular function | CCR chemokine receptor binding |
| GO_0042056 | Molecular function | chemoattractant activity |
| GO_0008201 | Molecular function | heparin binding |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0008009 | Molecular function | chemokine activity |
| Gene name | CCL15 |
| Protein name | C-C motif chemokine 15 (C-C motif chemokine ligand 15) C-C motif chemokine 15 (Chemokine CC-2) (HCC-2) (Leukotactin-1) (LKN-1) (MIP-1 delta) (Macrophage inflammatory protein 5) (MIP-5) (Mrp-2b) (NCC-3) (Small-inducible cytokine A15) [Cleaved into: CCL15(22-92); CCL15(25-92); CCL15(29-92)] |
| Synonyms | MIP5 SCYA15 NCC3 |
| Description | FUNCTION: Chemotactic factor that attracts T-cells and monocytes, but not neutrophils, eosinophils, or B-cells. Acts mainly via CC chemokine receptor CCR1. Also binds to CCR3. CCL15(22-92), CCL15(25-92) and CCL15(29-92) are more potent chemoattractants than the CCL15. . |
| Accessions | ENST00000617897.2 A0A087X1J9 ENST00000614050.1 ENST00000631730.1 Q16663 ENST00000614368.1 |
